Senseonics Holdings (SENS) Gross Margin (2015 - 2026)
Senseonics Holdings' (SENS) quarterly Gross Margin came in at 59.1% in Q2 2026, up 1216.0% year-over-year from 4.49% in Q2 2025, and little changed quarter-over-quarter from 59.26% in Q1 2026.
Analysis
Senseonics Holdings (SENS) Gross Margin (2015 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has reported Gross Margin for 12 consecutive years, with 59.1% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Gross Margin rose 1216.0% year-over-year to 59.1% in Q2 2026; TTM through Jun 2026 was 54.87%, a 3710.0% increase from a year earlier, with the FY2025 full-year figure at 44.71%, up 4234.0% from the prior year.
- Gross Margin was 59.1% for Q2 2026 at Senseonics Holdings, roughly flat from 59.26% in the prior quarter.
- Over five years, Gross Margin peaked at 59.26% in Q1 2026 and troughed at 95.03% in Q3 2024.
- A 5-year average of 20.84% and a median of 20.23% in 2022 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin tumbled 11425 bps in 2024 and soared 13787 bps in 2025, its largest moves.
- Over 5 years, Gross Margin stood at 11.11% in 2022, then climbed by 22 bps to 13.56% in 2023, then soared by 251 bps to 47.62% in 2024, then grew by 13 bps to 53.79% in 2025, then climbed by 10 bps to 59.1% in 2026.
- The last three Gross Margin figures came in at 59.1% (Q2 2026), 59.26% (Q1 2026), and 53.79% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 57.71% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 67.78% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 64.99% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 68.27% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 70.71% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 77.46% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 60.21% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 63.44% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 45.84% |
| 10 | Senseonics Holdings | 507.86 Mn | 267.25 Mn | 8.56 Mn | 59.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.10% |
| Mar 31, 2026 | 59.26% |
| Dec 31, 2025 | 53.79% |
| Sep 30, 2025 | 42.84% |
| Jun 30, 2025 | 46.94% |
| Mar 31, 2025 | 24.05% |
| Dec 31, 2024 | 47.62% |
| Sep 30, 2024 | -95.03% |
| Jun 30, 2024 | 6.13% |
| Mar 31, 2024 | 6.64% |
| Dec 31, 2023 | 13.56% |
| Sep 30, 2023 | 19.22% |
| Jun 30, 2023 | 10.11% |
| Mar 31, 2023 | 10.01% |
| Dec 31, 2022 | 11.11% |
| Sep 30, 2022 | 16.36% |
| Jun 30, 2022 | 22.19% |
| Mar 31, 2022 | 21.24% |
| Dec 31, 2021 | -11.78% |
| Sep 30, 2021 | -35.28% |